Senior Director, Field Medical Affairs

CG Oncology Inc• Remote, US,

8d•$230,000 - $270,000•Remote

About The Position

The Senior Director, Field Medical Affairs is the people and strategic leader of CG Oncology’s Medical Science Liaison (MSL) organization. This leader builds, develops, inspires, and leads a high-performing field medical team that serves as a trusted scientific interface between CG Oncology and the external medical community. The position calls for exceptional people leadership, emotional intelligence, active listening, and the ability to create alignment, accountability, and trust across a geographically dispersed organization. As a member of the Medical Affairs Leadership Team, the Senior Director develops and executes an insight-driven field medical strategy supporting clinical development, launch readiness, and CG Oncology’s transition to a commercial-stage oncology company. The role works closely with internal functions and executive leadership while maintaining Medical/Commercial guardrails, scientific independence, scientific rigor, integrity, and compliance. The Senior Director is accountable for MSL team performance and development, scientific engagement strategy, KOL development, medical insights generation and translation, field operations, and organizational effectiveness. The role translates enterprise priorities into clear field strategy and ensures that results are achieved in a way that reflects CG Oncology’s values and leadership behaviors.

Requirements

Advanced degree in life sciences, pharmacy, or a related field; Pharm.D., Ph.D., or M.D. required.
Twelve years of progressive Medical Affairs experience with significant field medical and MSL leadership responsibility.
Demonstrated success leading, coaching, developing, and retaining high-performing, geographically dispersed MSL teams.
Demonstrated ability to develop and execute field medical strategy aligned with Medical Affairs, clinical development, launch readiness, and enterprise objectives.
Experience building, scaling, or materially evolving a national MSL organization.
Oncology experience required.
Exceptional cross-functional collaboration with Commercial and enterprise partners while maintaining scientific independence and compliant guardrails.
Ability to translate complex scientific priorities and field insights into clear strategy, focused execution, and actionable enterprise recommendations.
Strong experience in KOL engagement, advisory boards, investigator-sponsored research, publication planning, and congress strategy.
Thorough knowledge of FDA regulations, GCP, the PhRMA Code, and Medical Affairs compliance requirements.
Exceptional interpersonal, active listening, communication, and presentation skills.
Leadership style and behaviors strongly aligned with CG Oncology’s values and culture.
Ability to travel by car or air, domestically and internationally; estimated travel is 25%.
Must be authorized to work for any employer in the United States; the company is unable to sponsor or take over sponsorship of an employment visa.

Nice To Haves

Experience supporting a first commercial launch or major oncology launch.
Immuno-oncology or immunotherapy experience.
Bladder cancer, urologic oncology, or gene therapy experience.

Responsibilities

Develop and execute Field Medical Affairs strategy aligned with Medical Affairs, clinical development, launch readiness, and corporate objectives.
Lead, coach, mentor, and develop a high-performing national MSL organization, establishing clarity, accountability, trust, and team cohesion.
Translate enterprise priorities into scientific objectives, priorities, KPIs, and measures of impact.
Create alignment through transparent communication, active listening, clear decision-making, and disciplined follow-through.
Anticipate the evolving needs of a company operating as both a clinical and emerging commercial organization.
Build connection across a remote field organization through intentional communication, in-person engagement, recognition, and consistent leadership presence.
Oversee field-based scientific exchange with healthcare professionals, investigators, and KOLs.
Ensure scientific information regarding company products, pipeline assets, and disease-state education is balanced, accurate, and compliant.
Lead advisory boards, investigator meetings, scientific congress activities, medical education programs, and other field medical initiatives.
Guide strategic KOL identification, development, and engagement in alignment with prioritized scientific objectives.
Maintain scientific rigor and guide MSLs in translating complex science into clear, relevant, and credible scientific exchange.
Build trusted partnerships with internal cross-functional and enterprise partners.
Bridge Field Medical and Commercial leadership through coordinated planning, appropriate information sharing, respect for functional roles, and clear Medical/Commercial guardrails.
Use scientific rigor, external insights, and enterprise judgment to influence strategy, respectfully challenge assumptions, and support aligned cross-functional decisions.
Partner with Commercial and launch teams to understand evolving customer and market needs while preserving Medical Affairs independence and compliance.
Model CG Oncology’s values and leadership behaviors, including respectful disagreement, ownership, accountability, intellectual honesty, and assuming positive intent.
Establish processes to collect, analyze, prioritize, and communicate field medical insights.
Translate external feedback into recommendations that inform clinical development, evidence generation, publication planning, Medical Affairs, and appropriate enterprise strategy.
Synthesize complex field information into concise recommendations and a preferred path forward.
Monitor scientific advances, competitive intelligence, and treatment landscape changes to support forward-looking decisions.
Recruit, develop, and retain exceptional MSL talent.
Provide frequent coaching, candid feedback, recognition, and individualized development.
Foster an inclusive, high-trust culture of collaboration, accountability, scientific excellence, continuous learning, and patient-centered leadership.
Create an environment where MSLs can respectfully challenge ideas, share scientific perspectives, and raise concerns while remaining aligned with team and enterprise decisions.
Lead performance management, succession planning, career development, and ongoing scientific and compliance training.
Develop field medical KPIs that measure impact, quality, strategic execution, and organizational effectiveness.
Manage field medical budgets, resource allocation, vendors, and external partnerships.
Drive continuous improvement, including appropriate use of modern technology and analytics.
Ensure activities comply with FDA regulations, GCP, the PhRMA Code, company policies, and applicable standards.
Promote high standards of ethics, integrity, scientific independence, and compliance.

Benefits

Highly competitive salaries.
Annual performance and merit reviews.
Annual performance bonuses.
Equity and special recognition.
Unlimited flexible time off.
14 holidays observed in 2026.
401(k) with a 100% company Safe Harbor match up to 4% of base salary.
Medical, dental, and vision plans (PPO and HDHP; Cigna/Principal).
Health Savings Account with annual company contribution, Flexible Spending Account, and dependent care FSA.
Company-paid long-term disability coverage and voluntary plans.
Company-paid life insurance equal to two times base salary and voluntary plans.
Voluntary legal and pet benefits, plus additional benefits.
Fully remote work environment.